BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7218763)

  • 1. Quantitative DNCB epicutaneous sensitization in leprosy patients and controls.
    Sivamani S; Garg BR; Lal S
    Lepr India; 1981 Jan; 53(1):45-51. PubMed ID: 7218763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precipitation of type-I (upgrading) reaction in leprosy by skin testing with antigen and irritants.
    Malhotra B; Das KD; Tutakne MA; Aggarwal SK
    Lepr India; 1983 Apr; 55(2):305-9. PubMed ID: 6632784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dinitrochlorobenzene contact sensitization in pulmonary tuberculosis.
    Malaviya AN; Sehgal KL; Kumar R; Dingley HB
    Clin Exp Immunol; 1975 Dec; 22(3):399-403. PubMed ID: 1225485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of levamisole on clinical outcome and DNCB conversion in leprosy patients. A long term study.
    Yagnik CS; Jogaikar DG; Mehta JM
    Lepr India; 1983 Jan; 55(1):68-70. PubMed ID: 6680021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological studies in psoriasis. The quantitative evaluation of cell-mediated immunity in patients with psoriasis by experimental sensitization to 2,4-dinitrochlorobenzene.
    Obalek S; Haftek M; Sliński W
    Dermatologica; 1977; 155(1):13-25. PubMed ID: 303184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cross allergies following sensitization with dinitrochlorbenzol (DNCB)].
    Djawari D; Körner E; Haneke E
    Hautarzt; 1980 Apr; 31(4):198-202. PubMed ID: 7399912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin sensitization to 2, 4 dinitrochlorobenzene (DNCB) in the first months of life.
    Cassimos C; Kanakoudi-Tsakalidis F; Spyroglou K; Ladianos M; Tzaphi R
    J Clin Lab Immunol; 1980 Mar; 3(2):111-3. PubMed ID: 7205930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous responses to antigens and irritants in patients of leprosy.
    Kumar B; Kaur S; Ganguly NK; Sharma S
    Lepr India; 1980 Jul; 52(3):405-10. PubMed ID: 7206636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the dinitrochlorobenzene (DNCB) sensitization test.
    Niwa Y; Niwa H; Kohmura J; Ou DW; Yokoyama MM
    Ann Allergy; 1982 Feb; 48(2):108-12. PubMed ID: 7199878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A technique for intensifying BCG sensitivity.
    Parmett SR; Klein E
    J Med; 1975; 6(3-4):213-6. PubMed ID: 1104733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNCB contact sensitization in leprosy: its comparison with other CMI tests.
    Jayasingh K; Bhatia VN
    Indian J Lepr; 1984; 56(2):207-11. PubMed ID: 6548491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNCB and PPD skin tests and prognosis in 152 patients with breast cancer. A prospective 2-year follow-up.
    Munzarová M; Kovarík J; Hlávková J; Popelínský L; Lauerová L
    Neoplasma; 1985; 32(1):45-50. PubMed ID: 3982560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [DNCB-skin specimens for immunodiagnosis].
    Sinn W
    Z Gesamte Inn Med; 1981 Sep; 36(17):602-7. PubMed ID: 7345806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients.
    Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A
    Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experiences with DNCB sensitization in normal human individuals of various age groups (author's transl)].
    Bürkle PA; Tönnesmann E; Ahnefeld S; Nobbe F; Federlin K
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(2):153-65. PubMed ID: 134535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin Tests for Evaluation of Cell Mediated Immunity in Leprosy.
    Mallya PS; Parvathi CN; Shetty JN; Nagesha CN
    Indian J Dermatol Venereol Leprol; 1989; 55(6):364-366. PubMed ID: 28128117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the DNCB skin test in patients with solid neoplasms].
    Mor C; Marcovina S; Moro E; Radice F; Russo R; Trinca E
    Arch Sci Med (Torino); 1978; 135(3):377-82. PubMed ID: 708088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated immunity during RDT and the outcome of transplantation.
    Watson MA; Hamilton DN; Briggs JD; Macpherson SG; Tsakiris D
    Proc Eur Dial Transplant Assoc; 1981; 18():387-93. PubMed ID: 7036157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential evaluation of DNCB reactivity in patients with primary lung cancer. Correlation with prognosis.
    Inoue H; Ishihara T; Kobayashi K; Fukai S
    J Thorac Cardiovasc Surg; 1978 Oct; 76(4):479-82. PubMed ID: 703354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood transfusion suppresses cutaneous cell-mediated immunity.
    Schot JD; Schuurman RK
    Clin Exp Immunol; 1986 Aug; 65(2):336-44. PubMed ID: 3791701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.